This video is sponsored by the Duke Clinical Medical Series.
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
Cindy L. Grines, MD, has indicated that she receives research/grant support from Amersham
Health, AstraZeneca, Aventis, Berlex, Eli Lilly, Esperion Therapeutics, GlaxoSmithKline,
Guidant, Innercool Therapies, Johnson & Johnson, Otsuka, Pfizer, and SciMed. She is a
consultant for Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Innercool
Therapies, Pfizer, and Sanofi-Synthelabo and is on the GlaxoSmithKline Global
Cardiovascular Advisory Board.
|
|